Form 4 for AGL agilon health, inc.
Accepted 2025-05-30 00:00:00 ET · period of report 2025-05-28 · accession 0001628280-25-028721 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-30 | 2025-05-28 | AGL | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +78.7K | 137.5K | +134% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-28 | A | A | 78,724 | $0.00 | 137,543 | D | — | — | (F1) Restricted stock units that vest in full on May 28, 2026, subject to continued service as a director. (F2) Includes restricted stock units. |